Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.24.1.1.u2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 2,763 $ 411 [1]
Accounts receivable 290 294 [1]
Inventories 2,579 2,737 [1]
Prepaid expenses and other current assets 606 641 [1]
Total current assets 6,238 4,083 [1]
Property and equipment, net 79 93 [1]
Other assets 613 647 [1]
Total assets 6,930 4,823 [1]
Current Liabilities:    
Accounts payable 3,257 2,320 [1]
Accrued liabilities 1,088 1,317 [1]
Total current liabilities 4,345 3,637 [1]
Warrant liabilities 4,621 5,460 [1]
Other liabilities 633 636 [1]
Total liabilities 9,599 9,733 [1]
Commitments and contingencies (Note 8) [1]
Series B Convertible Redeemable Preferred Stock, par value $0.0001; 375,000 shares authorized; 0 and 38,335 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively [1]   247
Stockholders' Deficit:    
Common stock, par value $0.0001; 300,000,000 shares authorized; 1,757,195 and 222,380 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 1 1 [1]
Additional paid-in capital 241,665 241,884 [1]
Accumulated deficit (244,335) (247,042) [1]
Total stockholders' deficit (2,669) (5,157) [1]
Total liabilities, convertible preferred stock and stockholders' deficit $ 6,930 $ 4,823 [1]
[1] The condensed consolidated balance sheet as of December 31, 2023 was derived from the audited consolidated balance sheet as of that date.